TCWM
ATNM icon

Total Clarity Wealth Management’s Actinium Pharmaceuticals ATNM Stock Holding History

Total Clarity Wealth Management’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-500
Closed -$4K – 979
2021
Q3 		$4K Buy
+500
New +$3.48K ﹤0.01% 834
2020
Q1 		– Sell
-20
Closed – – 121
2019
Q4 		$0 Buy
+20
New +$138 ﹤0.01% 683

Other funds holding ATNM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Total Clarity Wealth Management's ATNM Position: Q4 2021 in Review

Total Clarity Wealth Management sold out of Actinium Pharmaceuticals (ATNM) in Q4 2021, closing a stake of 500 shares — an estimated $4K sold.

Total Clarity Wealth Management first reported a position in ATNM in Q4 2019 and held it in 2 quarters. The position peaked at $4K in Q3 2021. 42 funds tracked by Wall St. Rank hold ATNM as of Q4 2021.

  • Total Clarity Wealth Management reported no remaining Actinium Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Total Clarity Wealth Management sold 500 Actinium Pharmaceuticals shares in Q4 2021, an estimated $4K.
  • Total Clarity Wealth Management first reported a position in Actinium Pharmaceuticals in Q4 2019 and held it in 2 quarters.
  • Total Clarity Wealth Management's Actinium Pharmaceuticals position peaked at $4K in Q3 2021.
  • 42 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q4 2021.

Based on Total Clarity Wealth Management's 13F filing for Q4 2021, filed 3 Feb 2022.